Heart defects—the most common type of birth defect—can result from mutations in the gene CHD4. Now, researchers know the key molecular details of what happens.
A new project to publish a controversial Cannabis genome to the blockchain may be big news for scientists seeking to head off patent battles and prove the originality of their research.
A report published on Tuesday highlights the frightening extent of sexual harassment in STEM, showing that it remains prevalent and largely unchanged.
Researches have identified molecular features of testicular germ cell cancers that could inform future efforts to improve treatment decisions and help monitor patients to see if their cancer has come back.
George Church talks about his disappointment with the Human Genome Project, the blistering price/performance improvements in both DNA synthesis and sequencing, and CRISPR’s strength and weaknesses, in addition to the improvements he hopes to see in its successors.
A new technique, dubbed intron seqFISH enables scientists to image 10,421 genes at once within individual cells.
Using genome-wide genetic approaches, researchers systematically screened for the loss of an additional gene that could rescue a genetic disease, and found it.
Figuring out what causes diseases like autism, schizophrenia and depression is tricky. Now Stanford University researchers are turning blood into brain cells to study these diseases in a dish.
Wrinkles aren’t just a sign of ageing on our appearance, but also occurs deep inside on a cellular level. These wrinkles appear to prevent our genes from functioning properly, researchers have found.
Dying cells generally have two options: go quietly, or go out with a bang. The latter, while more conspicuous, is also mechanistically more mysterious. Now, scientists have pinpointed what they believe is the molecular “code” that unleashes this more violent variety of cell death.
A new method can examine protein assembly in real time, in living cells, to find problems in the process and diagnose the resulting diseases, according to new research.
A new blood test for pregnant women detects with 75-80% accuracy whether their pregnancies will end in premature birth. The technique can also be used to estimate a fetus’ gestational age — or the mother’s due date — as reliably as and less expensively than ultrasound.
A research team has identified the essential role of a structural protein in the silencing of the inactive X chromosome, a process that prevents both copies of the same gene from being expressed in female mammals, which carry two copies of the X chromosome.